Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Medifast: Record Q2 Sales, Optimistic Q3
- Zacks.com submits: Medifast, Inc. MED is growing quickly as diet, health and fitness programs stay hot even in a slowing economy. Revenues rose 25% in the second quarter and the company recently said third quarter financials look strong. The company has a forward P/E of 9.97. Company Description...
- External links 2008-10-20
- Becton, Dickinson and Co. Poised for Growth
- Zacks.com submits: Becton, Dickinson and Company BDX offers a return on equity of 23%, exceeding the industry average of 17%. The company’s dividend yield of 1.7% is also ahead of the industry average as most of BDX’s peers pay no income. BDX is scheduled to release fiscal fourth...
- External links 2008-10-30
- Varian Medical Systems: Earnings Surprise, New Cancer Treatment Technology
- Zacks.com submits: Varian Medical Systems, Inc. VAR just reported another earnings surprise along with increased revenue. The company also released its newest technology for cancer treatment. Varian Medical Systems, Inc. is the world's leading supplier of equipment and software for treating cancer. The company is also a premier...
- External links 2008-11-06
- Almost Family Reports Healthy Quarter
- Zacks.com submits: Almost Family Inc. AFAM has gone on to set a new 52-week high after a spectacular third-quarter earnings announcement. Company Description by Zacks.com
- External links 2008-11-13
- ResMed: Record Quarterly Revenues, Great Valuations
- Zacks.com submits: ResMed Inc RMD announced record quarterly revenues and income. Shares are enticing as they trade at a discount to the industry averages. Company Description ResMed Inc. is a leading designer, manufacturer and distributor of medical equipment for treating and diagnosing sleep disordered breathing....
- External links 2008-11-26
- Chemed Corporation Showing Strong Growth
- Zacks.com submits: By Bill Wilton Chemed Corp. CHE is growing through its hospice care services and acquiring franchises across the country. The company is also repurchasing its stock and just reported solid quarterly earnings. Company Description by Zacks.com
- External links 2008-11-28
- Thoratec Swings Back into Profitability, Handily Beats Estimates
- Zacks.com submits: Thoratec Corp. THOR recently swung into profitability from last year, reporting strong third-quarter results that were fueled by the release of a product that was approved by regulators for sale in April. Estimates are on the move and so is Thoratec's share price. Company Description...
- External links 2008-12-04
- Cantel Medical Rallies After Another Strong Quarter
- Zacks.com submits: Cantel Medical Corp. CMN is rallying after reporting another strong quarter in early December. The current-year estimate has been rising for the last few months as analysts anticipate strong earnings growth from the company. Company Description by Zacks.com
- External links 2008-12-16
- Amylin Shares Find Support, But Upside Still Limited
- Zacks.com submits: We have been cautious on Amylin Pharmaceuticals, Inc. AMLN since the beginning of 2008, and we are still unconvinced that LAR will be approved on its first cycle FDA review. However, with the shares trading at multi-year lows, and the stock down 70% over the past...
- External links 2009-03-24
- Health Net May Be Volatile
- Zacks.com submits: Health Net, Inc. HNT is one of the nation's largest publicly traded multiregional managed care companies. The company recently reported better-than-expected 4Q08 financial results with net income of $63.1M, or EPS of $0.61, compared with $116.9M, or EPS of $1.10 in 4Q07. A highlight of the...
- External links 2009-03-24
- Osiris Hits a Speedbump in Crohn's Program
- Zacks.com submits: On March 27, 2009, Osiris Therapeutics OSIR announced it was stopping its phase III clinical trial program testing Prochymal for the treatment of acute Crohn’s disease CD due to a design flaw in the trial that was allowing for significantly higher-than-expected placebo response rates.The decision was...
- External links 2009-03-27
- Acorda Down on FDA Delay
- Zacks.com submits: This morning, Acorda Therapeutics ACOR received a “refuse to file” (RTF) letter from the U.S. FDA regarding its new drug application (NDA) for Fampridine-SR, the company’s novel therapy designed to improve walking ability in people with multiple sclerosis. According to management on the conference call...
- External links 2009-03-31
- Abbott's Stent Bests BSX's
- Zacks.com submits: Abbott Laboratories ABT reported long-term results comparison of years two and three for its Spirit II clinical trial at the i2 Summit at the American College of Cardiology's 58th annual scientific session. The trial compared the XIENCE V Everolimus Eluting Coronary Stent System ABT against Boston...
- External links 2009-04-07
- How Medicare Advantage Changes Could Affect Humana
- Zacks.com submits: On Monday April 6, 2009, the Centers for Medicare & Medicaid Services (CMS) announced that the national average growth percentage per capita for Medicare Advantage plans will rise 0.81% in 2010 compared with preliminary estimate of 0.5% announced Feb. 20. This is a measure of...
- External links 2009-04-08
- Dendreon's Positive IMPACT
- Zacks.com submits: This morning, Dendreon Corporation DNDN announced results of the long-awaited pivotal phase III IMPACT study of Provenge in men with advanced prostate cancer. In the news release and the conference call, management disclosed that the phase III study met its primary endpoint of improving overall survival...
- External links 2009-04-14
- Marked Improvement Bodes Well for Pozen
- Zacks.com submits: We are updating our financial model on Pozen POZN. Although GlaxoSmithKline GSK is not expected to report sales of Treximet until later in the month, we have seen data showing that prescription trends for the drug are showing a dramatic improvement over the past few weeks.For...
- External links 2009-04-15
- Abbott Earnings: Some Highs, Some Lows, Some Questions
- Zacks.com submits: This morning Abbott Laboratories, Inc. ABT reported financial results for the period ending March 31, 2009. Revenue for the first quarter came in at $6.7 billion, well below our estimate of $7.05 billion and the Street’s estimate of $7.06 billion. Revenue fell by almost 1% from...
- External links 2009-04-15
- Cautious on Two Hospice Providers
- Zacks.com submits: On April 21, 2009, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule to update the Medicare Hospice Wage Index for FY10. Payments to Medicare participating hospices are estimated to decrease by approximately 1.1% in FY10.The decrease in the hospice payments reflects a...
- External links 2009-04-24
- Theravance Narrows Its Losses
- Zacks.com submits: Theravance, Inc. THRX reported 1Q09 results on April 22, 2009.Revenue increased 70% to $9.5 million for the quarter compared to $5.6 million in the same period last year. The increase was primarily due to the recognition of the remaining deferred revenue of the LAMA program since...
- External links 2009-04-24
- Alcon Pharma: Facing Up to Its Challenges
- Zacks.com submits: Alcon Pharmaceuticals ACL faces some challenges in the near future: patent expirations, patent challenges, generic threats and softer pricing on certain of its products as a result of Medicare rebates. Additional near-term challenges come from slower top-line growth due to a weakening economy and negative...
- External links 2009-04-24
- << Previous
- page 1 of 7
- Next >>
Refining Tags
- Biotech (21 results)
- GlaxoSmithKline Plc. (8 results)
- Abbott Laboratories Inc. (8 results)
- Merck & Co. Inc. (7 results)
- Johnson & Johnson (6 results)
- Absolute Software Corp. (5 results)
- Pfizer Inc. (5 results)
- Seeking Alpha (4 results)
- Bristol-Myers Squibb Co. (4 results)
- Boston Scientific Corp. (4 results)
- Medtronic Inc. (4 results)
- US Market (4 results)
- Retail (3 results)
- Alcon (3 results)
- Forest Laboratories Inc. (3 results)
- Genzyme Corp. (3 results)
- Acorda Therapeutics Inc. (3 results)
- Finance (3 results)
- Baxter International Inc. (3 results)
